Incisive CT for Brazil SKD-Computed Tomography X-Ray System Model: 728146
FDA Device Recall #Z-2259-2023 — Class II — April 25, 2023
Recall Summary
| Recall Number | Z-2259-2023 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 25, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Philips North America |
| Location | Cambridge, MA |
| Product Type | Devices |
| Quantity | 20 units OUS |
Product Description
Incisive CT for Brazil SKD-Computed Tomography X-Ray System Model: 728146
Reason for Recall
Metal mounting box on the rotating scanner on rotor (heat exchanger box) located within the Incisive CT system may become expelled and make contact with other components and cause injury to user or if detached a loud noise will be emitted and the system will shut down
Distribution Pattern
Nationwide Foreign: China Algeria Argentina Australia Austria Azerbaijan Bahrain Bangladesh Belarus Belgium Bolivia Brazil Bulgaria Canada Chile China Colombia Czech Republic Ecuador Egypt France Germany Greece India Indonesia Iran Iraq Israel Italy Japan Jordan Korea, Republic of Kosovo Latvia Macedonia Mexico Moldova Netherlands Nigeria Pakistan Panama Philippines Poland Romania Russian Federation Saint Lucia Saint Pierre and Miquelon Saudi Arabia Serbia Slovakia Spain Sweden Taiwan Thailand Tunisia Turkey Turkmenistan United Kingdom Uzbekistan Viet Nam
Lot / Code Information
UDI-DI: (01)00884838104481(21) Serial Numbers: 540009 540008 540015 540012 540016 540017 540003 540004 540005 540006 540007 540001 540011 540000 540014 540013 540018 540010 540002
Other Recalls from Philips North America
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1156-2026 | Class II | Patient Information Center iX; Software Versio... | Dec 22, 2025 |
| Z-1204-2026 | Class II | Evolution Upgrade 1.5T. Product Codes (REF): ... | Dec 3, 2025 |
| Z-1215-2026 | Class II | SmartPath to dStream for 3.0T. Product Code (... | Dec 3, 2025 |
| Z-1207-2026 | Class II | Ingenia 3.0T. Product Code (REF): (1) 781342,... | Dec 3, 2025 |
| Z-1209-2026 | Class II | Ingenia Ambition S. Product Code (REF): 78210... | Dec 3, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.